Ptosis during hematologic malignancy in children.

Abstract

Neurological symptoms such as ptosis may develop due to either chemotherapeutic agents or involvement of the central nervous system (CNS) during hematologic malignancy. It is difficult to make this distinction according to clinical symptoms and magnetic resonance imaging findings. If the neurologic symptoms are increased, it is a warning of CNS involvement. Herein are described the clinical and neuroimaging features of three patients with hematologic malignancy who presented with ptosis.

DOI: 10.1111/ped.12238

3 Figures and Tables

Cite this paper

@article{Ekici2014PtosisDH, title={Ptosis during hematologic malignancy in children.}, author={Arzu Ekici and Ayten Yakut and {\"{O}zcan B{\"{o}r and Sevgi Yimenicioğlu and K{\"{u}rşat Bora Çarman and Suzan Şaylısoy}, journal={Pediatrics international : official journal of the Japan Pediatric Society}, year={2014}, volume={56 2}, pages={264-6} }